Published in Br J Cancer on July 25, 2005
Mind-Body Health in Uro-Oncology: Research Study | NCT03852030
Testicular cancer survivorship: research strategies and recommendations. J Natl Cancer Inst (2010) 1.76
Familial testicular germ cell tumors in adults: 2010 summary of genetic risk factors and clinical phenotype. Endocr Relat Cancer (2010) 1.41
Sex differences in primary hypertension. Biol Sex Differ (2012) 1.37
Male reproductive health after childhood, adolescent, and young adult cancers: a report from the Children's Oncology Group. J Clin Oncol (2012) 1.08
Romantic and sexual relationships, body image, and fertility in adolescent and young adult testicular cancer survivors: a review of the literature. J Adolesc Health (2010) 1.02
Evidence-based pragmatic guidelines for the follow-up of testicular cancer: optimising the detection of relapse. Br J Cancer (2008) 1.01
Reproductive outcomes for survivors of childhood cancer. Obstet Gynecol (2010) 0.98
Fertility preservation for cancer patients: a review. Obstet Gynecol Int (2010) 0.91
Testis-sparing surgery for benign and malignant tumors: A critical analysis of the literature. Indian J Urol (2008) 0.89
Perceptions of masculinity and self-image in adolescent and young adult testicular cancer survivors: implications for romantic and sexual relationships. Psychooncology (2010) 0.88
Testis cancer. Postgrad Med J (2007) 0.84
Endocrine late effects after total body irradiation in patients who received hematopoietic cell transplantation during childhood: a retrospective study from a single institution. J Cancer Res Clin Oncol (2011) 0.83
TRA-1-60(+), SSEA-4(+), POU5F1(+), SOX2(+), NANOG(+) Clones of Pluripotent Stem Cells in the Embryonal Carcinomas of the Testes. J Stem Cell Res Ther (2013) 0.83
Organ-sparing surgery is the treatment of choice in benign testicular tumors. World J Urol (2013) 0.83
Comment on 'Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors'. Br J Cancer (2013) 0.82
Long-term exposure to circulating platinum is associated with late effects of treatment in testicular cancer survivors. Ann Oncol (2015) 0.81
The genomic landscape of testicular germ cell tumours: from susceptibility to treatment. Nat Rev Urol (2016) 0.81
Sperm counts and endocrinological markers of spermatogenesis in long-term survivors of testicular cancer. Br J Cancer (2012) 0.80
Cross-cultural development of an EORTC questionnaire to assess health-related quality of life in patients with testicular cancer: the EORTC QLQ-TC26. Qual Life Res (2012) 0.80
Concise review: fertility preservation: an update. Stem Cells Transl Med (2012) 0.80
Adverse effects of common medications on male fertility. Nat Rev Urol (2015) 0.79
Etiology and early pathogenesis of malignant testicular germ cell tumors: towards possibilities for preinvasive diagnosis. Asian J Androl (2015) 0.78
Sperm banking and the cancer patient. Ther Adv Urol (2010) 0.76
Testis sparing surgery in a case of small unilateral testicular cancer. Turk J Urol (2013) 0.75
Clinical significance of androgen secretion disorders in men with a malignancy. Med Oncol (2017) 0.75
Cardiovascular disease as a long-term complication of treatment for testicular cancer. J Clin Oncol (2003) 3.10
The effects of induced hypogonadism on arterial stiffness, body composition, and metabolic parameters in males with prostate cancer. J Clin Endocrinol Metab (2001) 2.61
Risk of testicular cancer in subfertile men: case-control study. BMJ (1999) 1.77
Gonadal hormones in long-term survivors 10 years after treatment for unilateral testicular cancer. Eur Urol (2003) 1.71
Evaluation of long-term toxicity in patients after cisplatin-based chemotherapy for non-seminomatous testicular cancer. Ann Oncol (2002) 1.68
Effect of graded testicular doses of radiotherapy in patients treated for carcinoma-in-situ in the testis. J Clin Oncol (2002) 1.61
Fertility in Norwegian testicular cancer patients. Br J Cancer (2000) 1.59
Association between plasma total testosterone and cardiovascular risk factors in healthy adult men: The Telecom Study. J Clin Endocrinol Metab (1997) 1.37
Late relapse of germ cell tumors after cisplatin-based chemotherapy. Ann Oncol (1997) 1.33
Fertility after chemotherapy for testicular cancer. J Clin Oncol (1983) 1.32
Evaluation of long-term toxicity after chemotherapy for testicular cancer. J Clin Oncol (1996) 1.29
The effect of hypopituitarism on life expectancy. J Clin Endocrinol Metab (1996) 1.28
Gonadal function of patients treated with cisplatin based chemotherapy for germ cell cancer. J Urol (1997) 0.96
The impact of chemotherapy on Leydig cell function in long term survivors of germ cell tumors. Cancer (2001) 0.95
Semen quality and reproductive hormones before orchiectomy in men with testicular cancer. J Clin Oncol (1999) 0.93
Endocrinological late effects after chemotherapy for testicular cancer. Br J Cancer (1996) 0.93
Prediction of long-term gonadal toxicity after standard treatment for testicular cancer. Eur J Cancer (1991) 0.92
Long-term toxicity of chemotherapy for testicular cancer--the cost of cure. Br J Cancer (1990) 0.89
Long-term fertility and Leydig cell function in patients treated for germ cell cancer with cisplatin, vinblastine, and bleomycin versus surveillance. J Clin Oncol (1990) 0.89
Gonadal dysfunction in patients treated for metastatic germ-cell tumors. J Clin Oncol (1986) 0.89
Spermatogenesis after unilateral orchiectomy for testicular cancer in patients following surveillance policy. J Urol (2001) 0.89
[Reversible germ cell toxicity following aggressive chemotherapy in patients with testicular tumors: results of a prospective study]. Klin Wochenschr (1989) 0.88
Fatigue, sexual function and mood following treatment for haematological malignancy: the impact of mild Leydig cell dysfunction. Br J Cancer (2000) 0.87
Post-treatment fertility in patients with testicular cancer. I. Influence of retroperitoneal lymph node dissection on ejaculatory potency. Br J Urol (1985) 0.85
Dose-dependent impairment of testicular function in patients treated with cisplatin-based chemotherapy for germ cell cancer. Ann Oncol (1994) 0.84
Changes in BMI after treatment of testicular cancer are due to age and hormonal function and not chemotherapy. Br J Cancer (2003) 0.82
Pretreatment follicle-stimulating hormone: a prognostic serum marker of spermatogenesis status in patients treated for germ cell cancer. J Urol (1998) 0.81
Semen quality after treatment for testicular cancer. Eur Urol (1993) 0.79
High-dose carboplatin and etoposide for salvage chemotherapy of germ cell tumours. Eur J Cancer (1995) 0.79
Comparative genomics of the lactic acid bacteria. Proc Natl Acad Sci U S A (2006) 10.24
Cancer patients' information needs and information seeking behaviour: in depth interview study. BMJ (2000) 8.44
Radioimmunoassay for the measurement of adenosine 3',5'-cyclic phosphate. Proc Natl Acad Sci U S A (1969) 7.81
Diversity in the practice of district ethics committees. BMJ (1989) 7.54
On the Interpretation of Multi-Hit Survival Curves. Proc Natl Acad Sci U S A (1949) 5.96
Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer. J Clin Oncol (1997) 5.89
Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med (1985) 5.09
Communication of results of necropsies in north east Thames region. BMJ (1991) 4.00
Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) With epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer. J Clin Oncol (2002) 3.98
Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids. Circ Res (2000) 3.70
A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumours. Ann Oncol (2005) 3.53
Caesarean section: a treatment for mental disorder? Tameside & Glossop Acute Services Unit v CH (a patient) [1996] 1 FLR 762. BMJ (1997) 3.48
Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience. Ann Oncol (2008) 3.44
Intestinal fluid accumulation induced by oral challenge with Vibrio cholerae or cholera toxin in infant mice. Infect Immun (1977) 3.35
Effect of reactive pharmacy intervention on quality of hospital prescribing. BMJ (1990) 3.25
Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial. Lancet (1999) 3.16
Cardiovascular disease as a long-term complication of treatment for testicular cancer. J Clin Oncol (2003) 3.10
Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year. International Study Group. Thorax (1993) 2.81
A prospective randomised trial of protracted venous infusion 5-fluorouracil with or without mitomycin C in advanced colorectal cancer. Ann Oncol (1997) 2.71
European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol (2004) 2.65
Evaluation of adjuvant psychological therapy in patients with testicular cancer: randomised controlled trial. BMJ (1998) 2.39
Enzyme therapy in type 1 Gaucher disease: comparative efficacy of mannose-terminated glucocerebrosidase from natural and recombinant sources. Ann Intern Med (1995) 2.39
Bile acid transformations by microbial strains belonging to genera found in intestinal contents. Acta Pathol Microbiol Scand (1967) 2.33
Fusion of splicing factor genes PSF and NonO (p54nrb) to the TFE3 gene in papillary renal cell carcinoma. Oncogene (1997) 2.32
Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment. J Clin Oncol (2000) 2.29
Broadening the criteria for avoiding staging bone scans in prostate cancer: a retrospective study of patients at the Royal Marsden Hospital. BJU Int (2003) 2.29
Optimal planning target volume for stage I testicular seminoma: A Medical Research Council randomized trial. Medical Research Council Testicular Tumor Working Group. J Clin Oncol (1999) 2.25
Electrocardiographic and clinical criteria for recognition of acute myocardial infarction based on analysis of 3,697 patients. Am J Cardiol (1983) 2.18
Perfusion of the spleen with blood containing prostaglandin E1: transmitter liberation and uptake. Proc R Soc Lond B Biol Sci (1969) 2.11
The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20. Eur J Cancer (2005) 2.09
Royal Marsden phase III trial of fluorouracil with or without interferon alfa-2b in advanced colorectal cancer. J Clin Oncol (1995) 2.08
Detection of micrometastases in patients with primary breast cancer. Lancet (1983) 2.07
A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF). Ann Oncol (1994) 2.02
Expanded linkage map of Vibrio cholerae. Genetics (1979) 1.92
A population-based study of prostate cancer chemotherapy. Clin Oncol (R Coll Radiol) (2011) 1.92
Select flavonoids and whole juice from purple grapes inhibit platelet function and enhance nitric oxide release. Circulation (2001) 1.90
Self-transfer and genetic recombination mediated by P, the sex factor of Vibrio cholerae. J Bacteriol (1972) 1.90
Ataxia-telangiectasia: an interdisciplinary approach to pathogenesis. Medicine (Baltimore) (1991) 1.89
Orchiectomy alone for Stage I testicular non-seminoma. A progress report on the Royal Marsden Hospital study. Br J Urol (1983) 1.87
Attitudes of patients to randomised clinical trials of cancer therapy. Eur J Cancer (1998) 1.85
The treatment of metastatic germ-cell testicular tumours with bleomycin, etoposide and cis-platin (BEP). Br J Cancer (1983) 1.84
Structure of the integrin VLA-4 and its cell-cell and cell-matrix adhesion functions. Immunol Rev (1990) 1.83
Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trial. Br J Cancer (1999) 1.80
Proliferation of human lymphocytes in culture. Nature (1966) 1.76
Diffusion-weighted magnetic resonance imaging: a potential non-invasive marker of tumour aggressiveness in localized prostate cancer. Clin Radiol (2008) 1.76
A comparison of treatment planning techniques used in two randomised UK external beam radiotherapy trials for localised prostate cancer. Clin Oncol (R Coll Radiol) (2007) 1.75
The processing peptidase of yeast mitochondria: the two co-operating components MPP and PEP are structurally related. EMBO J (1988) 1.73
Medical Research Council prospective study of surveillance for stage I testicular teratoma. Medical Research Council Testicular Tumors Working Party. J Clin Oncol (1992) 1.73
Social class and changes in weight-for-height between childhood and early adulthood. Int J Obes (1988) 1.69
A test for the practical evaluation of male fertility by acridine orange (AO) fluorescence. Fertil Steril (1984) 1.68
FDG-PET in the prediction of survival of patients with cancer of the pancreas: a pilot study. Br J Cancer (2000) 1.68
Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects. Br J Cancer (2005) 1.68
The Second Medical Research Council study of prognostic factors in nonseminomatous germ cell tumors. Medical Research Council Testicular Tumour Working Party. J Clin Oncol (1992) 1.67
Weight history, glucose intolerance, and insulin levels in middle-aged Swedish men. Am J Epidemiol (1998) 1.66
Intensity modulated radiation therapy: a clinical review. Br J Radiol (2000) 1.62
A genetic register for von Hippel-Lindau disease. J Med Genet (1996) 1.61
Prognostic factors in hormone-resistant progressing cancer of the prostate. Ann Oncol (1992) 1.61
Progression of aortic stenosis. Role of age and concomitant coronary artery disease. Chest (1993) 1.61
Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study. BJU Int (2010) 1.60
Adjuvant or palliative chemotherapy for colorectal cancer in patients 70 years or older. J Clin Oncol (1999) 1.59
The noradrenaline content of the vas deferens of the guinea-pig. Proc R Soc Lond B Biol Sci (1970) 1.58
Rapid destructive osteoarthritis: clinical, radiographic, and pathologic features. Radiology (1992) 1.56
Prognostic factors for patients with advanced seminoma treated with platinum-based chemotherapy. Eur J Cancer (1997) 1.55
The mutational spectrum in Waardenburg syndrome. Hum Mol Genet (1995) 1.55
Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSA. Clin Radiol (2000) 1.54
Carboplatin or cisplatin? Lancet (1988) 1.53
Notes: a suitable case for audit. Postgrad Med J (1993) 1.53
Fatal accidental childhood injuries in Canada. Can J Public Health (1987) 1.52
Localization of DNA sequences in region Xp21 of the human X chromosome: search for molecular markers close to the Duchenne muscular dystrophy locus. Am J Hum Genet (1985) 1.52
Cost versus benefit in non-surgical management of patients with cancer. BMJ (1988) 1.50
Parameters in 7-alpha-dehydroxylation of bile acids by anaerobic lactobacilli. Acta Pathol Microbiol Scand (1968) 1.50
Predicting the risk of bleomycin lung toxicity in patients with germ-cell tumours. Ann Oncol (2003) 1.49
A randomized study of the use of a customized immobilization system in the treatment of prostate cancer with conformal radiotherapy. Radiother Oncol (2000) 1.49
Combination carboplatin and radiotherapy in the management of stage II testicular seminoma: comparison with radiotherapy treatment alone. Radiother Oncol (2001) 1.49
Acute toxicity in pelvic radiotherapy; a randomised trial of conformal versus conventional treatment. Radiother Oncol (1997) 1.47
Recovery of serum testosterone, LH and FSH levels following neoadjuvant hormone cytoreduction and radical radiotherapy in localized prostate cancer. Clin Oncol (R Coll Radiol) (2001) 1.46
Use of antisera to epithelial membrane antigen for the cytodiagnosis of malignancy in serous effusions. J Clin Pathol (1981) 1.46
Baseline quality of life predicts survival in patients with advanced colorectal cancer. Eur J Cancer (2002) 1.45
Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer. Ann Oncol (2012) 1.44
Testicular seminoma and non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2013) 1.43
Predicting normal tissue injury in radiation therapy. Int J Radiat Oncol Biol Phys (1991) 1.43
Endoscopic evaluation of the gastro-duodenal tolerance of short-term analgesic treatment with 25 mg diclofenac-K liquid capsules. Aliment Pharmacol Ther (2012) 1.43
Comparison of treatment techniques for conformal radiotherapy of the prostate using dose-volume histograms and normal tissue complication probabilities. Radiother Oncol (1995) 1.43
Regular review: Managing testicular cancer. BMJ (2001) 1.43
Evaluation of the efficacy of the VEEP regimen in adult Hodgkin's disease with assessment of gonadal and cardiac toxicity. J Clin Oncol (1995) 1.43
RAPPER: the radiogenomics of radiation toxicity. Clin Oncol (R Coll Radiol) (2013) 1.42
Using intact nerve to bridge peripheral nerve defects: an alternative to the use of nerve grafts. J Hand Surg Am (2001) 1.42
STAMPEDE: Systemic Therapy for Advancing or Metastatic Prostate Cancer--a multi-arm multi-stage randomised controlled trial. Clin Oncol (R Coll Radiol) (2008) 1.42
Neoadjuvant carboplatin before radiotherapy in stage IIA and IIB seminoma. Ann Oncol (2013) 1.41
A comparison of conformal and intensity-modulated techniques for oesophageal radiotherapy. Radiother Oncol (2001) 1.40
Developing, assessing, and refining quality of care criteria for a CHAMPUS mental health services demonstration. QRB Qual Rev Bull (1991) 1.40
Evaluating the effect of rectal distension and rectal movement on prostate gland position using cine MRI. Int J Radiat Oncol Biol Phys (1999) 1.39